1] Inserm, U910, Faculté de Médecine de La Timone, Marseille, France [2] Aix Marseille Université, Faculté de Médecine, Marseille, France [3] Assistance Publique Hôpitaux de Marseille, Département de Génétique Médicale et de Biologie Cellulaire, Hôpital d'Enfants de La Timone, Marseille, France.
1] Inserm, U910, Faculté de Médecine de La Timone, Marseille, France [2] Aix Marseille Université, Faculté de Médecine, Marseille, France.
Eur J Hum Genet. 2014 Mar;22(3):363-8. doi: 10.1038/ejhg.2013.135. Epub 2013 Jun 12.
MRXS5 or Pettigrew syndrome was described 20 years ago in a four generation family including nine affected individuals presenting with facial dysmorphism, intellectual disability, Dandy-Walker malformation and inconstant choreoathetosis. Four individuals had iron deposition in the basal ganglia seen on MRI or at autopsy. The mutation causing Pettigrew has remained elusive since the initial description of the condition. We report the identification of a mutation in the X-linked AP1S2 gene in the original Pettigrew syndrome family using X-chromosome exome sequencing. We report additional phenotype details for several of the affected individuals, allowing us to further refine the phenotype corresponding to this X-linked intellectual disability syndrome. The AP1S2 c.426+1 G>T mutation segregates with the disease in the Pettigrew syndrome family and results in loss of 46 amino acids in the clathrin adaptor complex small chain domain that spans most of the AP1S2 protein sequence. The mutation reported here in AP1S2 is the first mutation that is not predicted to cause a premature termination of the coding sequence or absence of the AP1S2 protein. Although most of the families affected by a mutation in AP1S2 were initially described as having different disorders assigned to at least three different OMIM numbers (MIM 300629, 300630 and 304340), our analysis of the phenotype shows that they are all the same syndrome with recognition complicated by highly variable expressivity that is seen within as well as between families and is probably not explained by differences in mutation severity.
MRXS5 或 Pettigrew 综合征在 20 年前被描述为四代家族性疾病,包括 9 名受累个体,表现为面部畸形、智力障碍、Dandy-Walker 畸形和不定型舞蹈手足徐动症。4 名个体的 MRI 或尸检显示基底节铁沉积。自最初描述该疾病以来,导致 Pettigrew 综合征的突变仍然难以捉摸。我们使用 X 染色体外显子组测序在最初的 Pettigrew 综合征家族中鉴定出 X 连锁 AP1S2 基因突变。我们报告了几个受累个体的附加表型细节,使我们能够进一步细化与这种 X 连锁智力障碍综合征相对应的表型。AP1S2 c.426+1G>T 突变在 Pettigrew 综合征家族中与疾病共分离,导致跨 AP1S2 蛋白序列大部分的网格蛋白衔接子复合物小链结构域缺失 46 个氨基酸。这里报道的 AP1S2 突变不是预测导致编码序列提前终止或 AP1S2 蛋白缺失的第一个突变。虽然大多数受 AP1S2 突变影响的家族最初被描述为具有不同的疾病,分配给至少三个不同的 OMIM 编号(MIM 300629、300630 和 304340),但我们对表型的分析表明,它们都是相同的综合征,由于高度可变的表达性而使识别变得复杂,这种表达性既见于家族内,也见于家族间,并且可能不是由突变严重程度的差异引起的。